If there has been significant growth from week 1 I am sure that would announce it, that can only be good for the SP. Especially if the CR is done at a 15%-20% discount.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%